ATEC to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference

Rhea-AI Summary

Alphatec Holdings, Inc. (ATEC) announced that CFO Jeff Black will present at the H.C. Wainwright BioConnect 2021 Conference from January 11-14, 2021. The pre-recorded presentation will be available on demand for 90 days starting January 11 at 6 A.M. ET. Interested viewers can access it via this link. ATEC focuses on innovative spine surgery solutions and aims to become the standard bearer in the industry.

CARLSBAD, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that Jeff Black, Executive Vice President and Chief Financial Officer, will present virtually at the H.C. Wainwright BioConnect 2021 Conference, which will be held January 11 through 14, 2021.  The pre-recorded presentation will be accessible on demand for 90 days beginning January 11, 2021, at 6 A.M. ET via this link. The accompanying presentation materials will be available from the Investor Relations page of the Company's corporate website at www.atecspine.com.

About Alphatec Holdings, Inc.

Alphatec Holdings, Inc. (ATEC), through its wholly-owned subsidiaries, Alphatec Spine, Inc. and SafeOp Surgical, Inc., is a medical device company dedicated to revolutionizing the approach to spine surgery through clinical distinction.  ATEC’s Organic Innovation Machine is focused on developing new approaches that integrate seamlessly with the SafeOp Neural InformatiX System to safely and reproducibly treat spine’s various pathologies and achieve the goals of spine surgery.  Alphatec’s vision is to become the Standard Bearer in Spine.  For more information, visit us at www.atecspine.com.

Forward-Looking Statements

Statements made during the investor events referenced herein may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management's current expectations and are subject to many risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties, and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. A list and description of such factors, risks and uncertainties can be found in the Company’s most recent annual report, and any subsequent quarterly and current reports, filed with the Securities and Exchange Commission. ATEC disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise unless required by law.

Investor/Media Contact:
Tina Jacobsen
Investor Relations
760) 494-6790
investorrelations@atecspine.com

Company Contact:
Jeff Black
Chief Financial Officer
Alphatec Holdings, Inc.
investorrelations@atecspine.com

FAQ

When is the H.C. Wainwright BioConnect 2021 Conference for ATEC?

The conference will be held from January 11 to January 14, 2021.

Who will represent ATEC at the BioConnect Conference?

Jeff Black, the Chief Financial Officer, will present on behalf of ATEC.

How can I access ATEC's presentation after the conference?

The pre-recorded presentation will be available on demand for 90 days, starting January 11, 2021, at 6 A.M. ET.

Where can I find more information about ATEC's innovative spine solutions?

More information can be found on ATEC's corporate website at www.atecspine.com.

What is the focus of ATEC's innovations in spine surgery?

ATEC focuses on developing new approaches that integrate with the SafeOp Neural InformatiX System for treating spine pathologies.